Multi-institutional Analysis of 200 COVID-19 Patients treated with ECMO: Outcomes and Trends

An abstract has been written for submission to the Eastern Cardiothoracic Surgical Society 2021 Meeting, to include a manuscript and presentation. It has been accepted for publication in The Annals of Thoracic Surgery. The work examines the role of ECMO in the management of patients with COVID-19 as it continues to evolve. The purpose is to review a multi-institutional clinical experience in 200 consecutive patients at 29 hospitals with confirmed COVID-19 supported with ECMO.

The work states: 

       “A prospective, multi-institutional cohort study was conducted of all patients with confirmed COVID-19 who were supported with ECMO at 29 different hospitals. Supplementary Table 1 documents the regional distribution of these 200 patients in 18 states at 29 hospitals in the United States. A multi-institutional database was created and utilized to assess these patients. This database is prospectively maintained on all patients and has been used for data collection and analysis. Data captured included patient characteristics, pre-COVID-19 risk factors and comorbidities, confirmation of COVID-19 diagnosis, features of ECMO support, specific medications utilized in an attempt to treat COVID-19, and short-term outcomes through hospital discharge.” 

To learn more about this work, click here

A big congratulations to all who contributed to this endeavor: Jeffrey P. Jacobs, MD, Alfred H. Stammers, MSA, James D. St. Louis, MD, J.W. Awori Hayanga, MD, Michael S Firstenberg, MD, Linda B. Mongero, CCP, Eric A. Tesdahl, PhD, Keshava Rajagopal, MD, PhD, Faisal H. Cheema, MD, Kirti Patel, CCP, Tom Coley, CCP, Anthony K. Sestokas, PhD, Marvin J. Slepian, MD, and Vinay Badhwar, MD.